Comparison of Patient Characteristics Between High-/Low-Metabolism Groups
| Characteristic | Low-metabolism group, SUVmax ≤ 9.0 (n = 46) | High-metabolism group, SUVmax > 9.0 (n = 29) | P |
| Primary tumor site (n) | 0.013 | ||
| Gallbladder cancer | 12 (26.1%) | 16 (55.2%) | |
| IHCC | 14 (30.4%) | 8 (27.6%) | |
| EHCC | 17 (37.0%) | 2 (6.9%) | |
| AoV cancer | 3 (6.5%) | 3 (10.3%) | |
| Histologic differentiation (n) | 0.034 | ||
| WD | 1 (2.6%) | 2 (13.3%) | |
| MD | 31 (81.6%) | 7 (46.7%) | |
| PD | 6 (15.8%) | 6 (40.0%) | |
| c-Myc, positive | 3 (12,5%) | 9 (56.2%) | 0.005 |
| Initial presentation at enrollment (n) | <0.001 | ||
| Metastatic disease | 14 (30.4%) | 21 (72.4%) | |
| Recurrent disease | 32 (69.6%) | 8 (27.6%) | |
| Mean WBC (μL) | 5,980.4 ± 1,857.4 | 7,473.1 ± 3,032.8 | 0.010 |
| Mean no. of organs with 18F-FDG uptake | 1.5 ± 1.1 | 2.3 ± 1.0 | 0.004 |
| Mean no. of lesions with 18F-FDG uptake | 2.9 ± 3.5 | 7.0 ± 7.9 | 0.012 |
WD = well differentiated; MD = moderately differentiated; PD = poorly differentiate; WBC = white blood cell.